A PATHOLOGICAL STUDY ON BORDERLINE OVARY TUMORS

被引:0
|
作者
Rehman, Toheed [1 ]
Hassan, Khalid [2 ]
Gul, Wahid [3 ]
机构
[1] Mardan Med Complex, Mardan, Pakistan
[2] BHU Hayaseri Dir Lower Temergara Maidan, Lahore, Pakistan
[3] Lady Reading Hosp, Peshawar, Pakistan
来源
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2019年 / 6卷 / 06期
关键词
Borderline Ovarian Tumors; Fertility Sparing Cancer; Fertility Preserving Surgery; Chemotherapy; Radiotherapy; CONSERVATIVE TREATMENT; OOPHORECTOMY; RECURRENCE; OUTCOMES; CANCER; IMPACT; WOMEN;
D O I
10.5281/zenodo.3258825
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: The aim of this study is to describe occurrence and treatment of BOTs (Borderline Ovarian Tumors) in under developing countries like Pakistan. Methodology: It is an observational study of patients suffering from borderline ovarian tumors, for the duration of 10 years from 2008 to 2018 at Lady Reading Hospital Peshawar. This research work includes observation of types, characteristics and cure of BOTs. We retrieved and classified the calculated data. Results: We identified 86 patients suffering from borderline ovarian tumors with an average age of thirty-five years. According to our research, 42 patients were suffering from serous borderline ovarian tumors, 43 patients were suffering from mucinous borderline ovarian tumors and one patient was suffering from mixed typed. We categorized patients by the usage of international federation of gynecology and obstetrics (FIGO) standards. The complete removal of tumor occurred in 70 patients. There were 43 patients, who experienced FPS (fertility preserving surgery). After the duration of 31.50 months, seventy-three patients were having no disease. There was reappearance of disease in thirteen patients. The factors responsible for recurrence of invasive tumors are; having age more than 40 years, partial surgery and current stage of disease. Conclusion: Although BOTs is less harmful disease, there is possibility of recurrence in patients having age more than 40 years, not-completed surgery or higher stage at the time of treatment. FSS is considerable, in case of young patients. To minimize the relapse of the disease removal of tumor and treatment for a long time is necessary.
引用
收藏
页码:13151 / 13156
页数:6
相关论文
共 50 条
  • [31] Borderline Mucinous Tumors of the Ovary: Updates in Diagnosis
    Lim, Diana
    Oliva, Esther
    AJSP-REVIEWS AND REPORTS, 2016, 21 (05): : 214 - 221
  • [32] THERAPY AND COURSE OF 105 BORDERLINE TUMORS OF THE OVARY
    WIENOLD, J
    SAREMBE, B
    RICHTER, P
    ZENTRALBLATT FUR GYNAKOLOGIE, 1989, 111 (11): : 721 - 727
  • [33] Management of borderline tumors of the ovary:: State of the art
    Tropé, C
    Kaern, J
    SEMINARS IN ONCOLOGY, 1998, 25 (03) : 372 - 380
  • [34] SEROUS BORDERLINE TUMORS OF THE OVARY - A CLINICOPATHOLOGICAL, IMMUNOHISTOCHEMICAL, AND QUANTITATIVE STUDY OF 44 CASES
    DENICTOLIS, M
    MONTIRONI, R
    TOMMASONI, S
    CARINELLI, S
    OJEDA, B
    MATIASGUIU, X
    PRAT, J
    CANCER, 1992, 70 (01) : 152 - 160
  • [35] Serous borderline tumors of the ovary:: A clinicopathologic and DNA ploidy study of 48 cases
    Guerrieri, C
    Högberg, T
    Fristedt, S
    Sullivan, S
    Simonsen, E
    Boeryd, B
    LABORATORY INVESTIGATION, 1999, 79 (01) : 118A - 118A
  • [36] Serous tumors of the ovary (borderline tumors and carcinomas) with and without micropapillary features
    Prat, J
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (01) : 25 - 28
  • [37] Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute
    Sahraoui, Ghada
    Fitouri, Asma
    Charfi, Lamia
    Driss, Maha
    Slimane, Maher
    Hechiche, Monia
    Mrad, Karima
    Doghri, Raoudha
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41 : 349
  • [38] Borderline Tumors of the Ovary: Clinical Course and Prognostic Factors
    Ewald-Riegler, Nina
    du Bois, Oya
    Fisseler-Eckhoff, Annette
    Kommoss, Friedrich
    Harter, Philipp
    Traut, Alexander
    Hils, Rita
    du Bois, Andreas
    ONKOLOGIE, 2012, 35 (1-2): : 28 - 33
  • [40] Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary
    Odegaard, Elin
    Davidson, Ben
    Elgaaen, Bente Vilming
    Fagerhol, Magne K.
    Engh, Vibeke
    Onsrud, Mathias
    Staff, Anne Cathrine
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (04) : 418.e1 - 418.e7